[GLMD] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[GLMD] Galmed Pharmaceuticals Ltd.
Announcement Date
12-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -88.12%
Quarter Report
GLMD's Result
GLMD's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 0 0 2,038 1,085 467 -
PBT -17,866 -32,467 -28,771 -20,461 -9,781 -12,299 -16,847 0.98%
Tax 705 -519 -1,161 -1,920 75 12,364 106 37.11%
NP -18,571 -31,948 -27,610 -18,541 -9,856 -12,299 -16,953 1.53%
Tax Rate - - - - - - - -
Total Cost 18,571 31,948 27,610 18,541 11,894 13,384 17,420 1.07%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 -483.61 -1,133.55 -3,630.19 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -11.08 -19.48 -19.46 -13.17 -8.15 -14.77 -22.36 -11.03%
EPS Diluted -11.08 -19.48 -19.46 -13.17 -8.15 -14.77 -22.36 -11.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.